Member Info for wyndrum

Thanks Ronnie

Yes, CI, got very lucky on that one! (makes a change Ha ha!) Joking aside it seems like something is up. still a little while away from the results so I don't think its that...maybe some big buyig (II?)

Oh well, just enjoy the ride I spose.

Somethings going on.....

Bought WOSG today too. tight stop at 758p as a reversal looks to be underway. 1st target 820p but 874p looks doable to me.

Year end figures next month. I am expecting the forecast to be pretty positive as more store opening are coming on line every quarter. THE PEG is very low at .30 (Anything below 1 is seen as good value). Just feels like a re-rating is due but thats almost certainly me indulging in wishful thinking.

Hi Ci, well, Yesterday after the rise I expected a higher finishing RSI but it only moved a few points to 70.

On that basis I bought a modest amount this morning at open at 27.26p My "logic" was 30p is still a target but I thought the retrace might not be down to the mid 20's so a price around mid 26p (didn't quite get in there but...) would seem ok.

The other e scenario is that it goes through 30p and then retraces back to it, so i would get in at 31p ish.

So my options were get in now and pay too much if it falls to 24p say, or wait and potentially get in at 31p.

So I have bought with half my funds I had allocated to it. I will add the other half at either 24p or 31p (1st Target is 46p)

"what do they mean by integrated and differentiated???"

presumably (and I know it was probably rhetorical), Affimers as the DX tool. (That obviously ticks both boxes.)

It could be that AVCT have been disappointed with the slow take up thus far and think they can do a better job commercialising this strand of the business themselves.

Big day tomorrow....

The SP suggests it will be a (relatively) non-event.. (which is the usual outcome of updates so that's understandable)

Well, perhaps it would be better to say that no SP-shattering news is expected.

Probably a mixed bag with some good news about the trial, but countered by long lead times. Hopefully income from LD holding up but no "breakthrough" in sales.

I don't expect any news on listings and my expectations have been lowered to a steady-as-she-goes while we wait for P1a to complete.

Still, you never know, this might be the time they surprise the market to the upside.... You place your bet and.... oh sorry.... we don't gamble here....

RD, I think it comes down to whow AVCt want to go forward.

Has Starbright pointed out the main reason companies list is to have access to raising funds.

If AVCT want to go it alone then they need perhaps a bigger and more receptive market. If they get a big cash inflow then that may negate the need to go elsewhere.

Its just part of the "uncertainty" of direction that AVCT are currently in.

Hopefully it will be a good deal clearer this week, otherwise its going to carry on drifting I think, unless or until a substantial milestone payment is announced, (or some other big influx of monies).

Hi D, Charts are not an exact thing. Its just really trying to skew the odds into the buyer/seller's favour.

At close Friday it was 67 on the RSI, I wait for 80 (as you know) before deciding what to do but anything above 70 is an indication of being over bought, so at 67 it was too high/close for me to want to buy this morning given the spread.

So I will see where it finished tonight and then look for a retrace as a possibilty to get in.

The other thing is never to get too anxious on stocks (its the "not caring" thing), as there is always a chance you miss out if the stock does not do what you thought it would, but there are always other opportunities on other stocks out there.

To me, its just numbers, not companies.

Hi D, I bought a small amount last week. (As you know I am not averse to jumping on a band wagon and momentum does not normally stop dead.) I am betting 12.18 is the low of the retrace. A close above 13.22p would confirm.

thats fine GM, but it was RAH that said what the SP should be and he said it is undervalued on the basis that the market has no understanding whatsoever of the science, not me.

I was just responding to his simplistic (in the extreme) view that the SP is only about the future potential of the science with no regard for the fundamental business model which right now is very unclear.

(It also begs the question if the market is so stupid why isn't he a millionaire already with all the other stupid SP's out there.)

"Market says there is a 95% chance things will go wrong. Market is thick as mince."

Oh good God, i thought we had all agreed now it was about the money!

RAH for reasons that I can only guess, is deliberately being opaque about this.

There have been delays to the timelines of the Trial and in fact significant ones. This has thrown up a QUESTION of if there are enough funds to get to the end or will extra finance be needed.

IF, IF extra funds are needed then that will have an effect on the SP. The market, (Unlike many here), do in fact like making money at reduced risk.

They are waiting for a clearer picture on the what's in the coffers.

Its not rigged, its not stupidity, its not ignorance. It is straight forward money management.

Right now with the constant issuing of shares to pay back the bond, means that we are in fact currently in the middle of a RI. (albeit spread out over a longer time frame)/You do get that RAH, don't you?

Hi Guys, sold Angle a while back so have not looked at it for a while. Certainly the update is positive and the biggest thing is the cash on hand (imo). Looks good for 12 months .

Chartwise its in no mans land. Obviously a great surge but the resistance is now much closer at and around 30p.

That on the chart looks stubborn so will be a great buying signal if/when it goes through.

The 2 most likely options looks to me, is either it carries on 20 28-30p before retracing to around 23.5-24p or will retrace now to there before having a proper go at 30p.

(On balance and with the RSI at 67 its a difficult call. The reason its hard to say is because if you were buying you would either wait for a close above 30p ish or wait for a retrace so there is not much incentive to buy at this price right now given the spread.) Good Luck

Now you have highlighted AGL I will keep tabs on this and either get in (if I can) around 23 ish or if not 30p ish.

Rog, my advice (fwiw) is not to get too hung up on body language etc. One, because we had all that nonsense here every time DM made an interview and also, these people are coached. "just give a slight hint of a smile here when you say....and there..... at these points, and that will help give confidence to investors" etc.

This is just about drilling. if, when, or maybe. Thats the ball game.

LW,

bought more just now as to sell you get 6.66p. Its a bit early as I prefer close prices but there seems to be upward momentum now in the SP and I think if it continues the spread might widen.

Morning D, (and anyone else who may pop by),

Do you still own any HE1? I bought more this morning as its above a break out of 6.65p. (its intra day and its a bit tentative from a TA pov but I think it has upward momentum on its side).

The target for me is to go at least to 8.5 so about a 30% gain on offer. Diifficult to have a rigid stop on this one because its either going to drill or not and if for some reason it doesn't its likely to be game over, so my investment amount is tailored accordingly.

"Only new info will be financials" except that can easily lead to update on the trial if there has been some dosing and at what level and if there has been an initial result, all under the guise of timelines to commercial considerations.

I do think at this stage, given the extra time this has taken and the so far outstanding success of the trial that AVCT need to give as clear and detailed a picture of what is happening currently and where this company is going.

If there is a desire for better coms then this is surely it. I hope they don't disappoint.

"We don’t know there won’t be any STS patients in C5. There could be. There could not. There’s no bar from STS patients in C5, C6, C7."

Whats the basis of that assumption when the whole point of this phase of the trial is safety not efficacy and thus far it has deliberately targeted non dox responsive tumours?

"Right Mr Wyn what happens if P1 b is undertaken in the states with ODD as its UNIQUELY placed"

I don't know cj, is that happening now? if not when will that be? and when will it finish?

What happens if AVCT get offered $5b be bought out?

Many here don't admit there are so many different potential outcomes that they have no idea which one will happen or indeed when, all having a different affect on their investment. It's a gamble... but I understand no one here actually admits that.

Kong, if you read the posts you would see that I never trash the company. I simply offer imo, more realistic views of the world that AVCT inhabit and recognise the importance of cash flow and money in sustaining a business.

Most here focus entirely on the tech which they actually know only what AVCT tells them, so there is no insight at all from this strand of posts other than to give a warm fuzzy feeling at how smart AVCT are and therefore how smart they are to hold the stock.

AVCT is a business. To be successful they need to make money.

When will that be? Currently I have no idea. I am pinning my hopes on a buy out.

Hope so Em, but heres the thing. P1b was meant to finish this summer.

P1a might not finish until Q3 then there is 2 months of data collation, so you tell me, when will P1b start, let alone finish? And the longer it takes, then throws out the original cash raise projections.

That imo, has been the weighty anchor on the SP appreciation. (It always comes down to money)